特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
963058

COVID-19診断の世界市場:製品・サービス別、サンプルタイプ別、技術タイプ別(抗体検査、PCR検査)、モード別、最終用途別の市場規模、シェアおよび動向分析、セグメント別予測(2020年~2027年)

COVID-19 Diagnostics Market Size, Share & Trends Analysis Report By Product & Service, By Sample Type, By Technology Type (Antibody Testing, PCR Testing), By Mode, By End-use, And Segment Forecasts, 2020 - 2027

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 150 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.59円
COVID-19診断の世界市場:製品・サービス別、サンプルタイプ別、技術タイプ別(抗体検査、PCR検査)、モード別、最終用途別の市場規模、シェアおよび動向分析、セグメント別予測(2020年~2027年)
出版日: 2020年09月03日
発行: Grand View Research, Inc.
ページ情報: 英文 150 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のCOVID-19診断の市場規模は、2020年から2027年の予測期間中、CAGR 3.1%で成長し、2027年までに246億米ドルに達すると予想されています。集団検査の必要性の増加と感染症診断の効率性が、市場成長に大きく貢献する要因となっています。 COVID-19の症例数が指数関数的に増加しているため、迅速で使いやすい診断および血清学的検査を開発する必要性も高まっています。これは、新興企業と新規市場参入企業に機会をもたらし、市場収益の成長を促進しています。

Tele2、H&M、Spotifyなどのスウェーデンの大手企業は、検査で陽性の社員と感染していない社員を区別するための集団検査に取り組んでいます。さらに、主要企業は、感染症の封じ込めの必要性の高まりに対応するために、診断検査の作成と供給を加速し続けています。例えば、2020年5月、Rocheは英国公衆衛生サービスによって100%正確であると認められている抗体検査を導入しました。

当レポートでは、世界の COVID-19診断市場について調査分析し、市場および業界の見通し、セグメント別・地域別の見通しのほか、競合情勢について、体系的な情報を提供しています。

目次

第1章 調査方法と範囲

第2章 エグゼクティブサマリー

第3章 業界の見通し

  • 親市場
  • 技術の浸透と成長の見通しのマッピング、2020年
  • 市場力学
    • 市場の成長要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題分析
  • COVID-19診断市場-ポーターの分析
    • ポーターの分析
  • COVID-19診断市場- SWOT分析
    • 政治的および法的
    • 経済的
    • 技術的
  • COVID-19診断市場:企業のポジショニング分析
  • COVID-19診断市場:各国の医療費と資金調達のシナリオ
    • 米国
    • 中国
    • ブラジル
    • ドイツ
    • その他
  • COVID-19診断市場-規制の枠組み
  • スワブ市場への影響
    • ウイルス輸送媒体の生産不足
    • ウイルス輸送媒体市場をリードする企業

第4章 製品・サービス別市場の事業分析

  • 試薬とキット
  • 器具
  • サービス

第5章 サンプルタイプ別市場の事業分析

  • COVID-19診断市場:サンプルタイプ市場の動向分析
  • 鼻咽頭スワブ
  • 口腔咽頭スワブ
  • 血液
  • その他

第6章 検査タイプ別市場の事業分析

  • COVID-19診断市場:検査タイプ別市場の動向分析
  • 分子(PCR)検査
  • 抗原ベースの検査
  • 抗体(血清学)検査
  • その他の検査

第7章 モード別市場の事業分析

  • COVID-19診断市場:モード別市場の動向分析
  • ポイントオブケア(PoC)検査
  • 非ポイントオブケア(非PoC)検査

第8章 最終用途別市場の事業分析

  • COVID-19診断市場:最終用途別市場の動向分析
  • 研究所
  • 病院
  • 診断センターとクリニック
  • 調査機関

第9章 地域別市場の事業分析

  • COVID-19診断市場:地域別市場の動向分析、2020年および2027年
  • 北米
  • 欧州
  • アジア太平洋地域
  • 中南米
  • 中東・アフリカ(MEA)

第10章 競合情勢

  • 企業/競合分類 (主要イノベーター、市場リーダー、新興企業)
  • 戦略の枠組み
  • 市場参入分類
  • 最新動向およびインパクト解析、主要市場参入企業別
  • 企業プロファイル
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific, Inc.
    • PerkinElmer, Inc.
    • 1drop, Inc.
    • Veredus Laboratories
    • ADT Biotech Sdn Bhd
    • altona Diagnostics GmbH
    • bioMerieux SA
    • Neuberg Diagnostics
    • Abbott Laboratories
    • Luminex Corporation
    • Laboratory Corporation of America Holdings
    • Hologic Inc
    • Quest Diagnostics, Inc.
    • Quidel Corporation
    • ALDATU BIOSCIENCES
    • Mylab Discovery Solutions Pvt Ltd.
    • Danaher Corporation
図表

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 Incidence rate of COVID-19 in North America
  • TABLE 3 Incidence rate of COVID-19 in Europe
  • TABLE 4 Incidence rate of COVID-19 in Asia Pacific
  • TABLE 5 Incidence rate of COVID-19 in Latin America
  • TABLE 6 Incidence rate of COVID-19 in Middle East and Africa
  • TABLE 7 Specimen collection and storage for COVID-19 testing
  • TABLE 8 Different COVID-19 diagnostic tests based on different technologies
  • TABLE 9 North America COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 10 North America COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 11 North America COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 12 North America COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 13 North America COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 14 The U.S. COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 15 The U.S. COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 16 The U.S. COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 17 The U.S. COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 18 The U.S. COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 19 Canada COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 20 Canada COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 21 Canada COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 21 Canada COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 23 Canada COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 24 Europe COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 25 Europe COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 26 Europe COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 27 Europe COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 28 Europe COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 29 Germany COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 30 Germany COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 31 Germany COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 32 Germany COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 33 Germany COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 34 The U.K.COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 35 The U.K.COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 36 The U.K.COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 37 The U.K.COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 38 The U.K.COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 39 France COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 40 France COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 41 France COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 42 France COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 43 France COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 44 Italy COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 45 Italy COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 46 Italy COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 47 Italy COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 48 Italy COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 49 Spain COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 50 Spain COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 51 Spain COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 52 Spain COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 53 Spain COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 54 Russia COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 55 Russia COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 56 Russia COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 57 Russia COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 58 Russia COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 59 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 60 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 61 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 62 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 63 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 64 China COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 65 China COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 66 China COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 67 China COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 68 China COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 69 India COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 70 India COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 71 India COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 72 India COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 73 Japan COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 74 Japan COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 75 Japan COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 76 Japan COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 77 Japan COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 78 South Africa COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 79 South Africa COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 80 South Africa COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 81 South Africa COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 82 South Africa COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 83 Australia COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 84 Australia COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 85 Australia COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 86 Australia COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 87 Australia COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 88 Latin America COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 89 Latin America COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 90 Latin America COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 91 Latin America COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 92 Latin America COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 93 Brazil COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 94 Brazil COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 95 Brazil COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 96 Brazil COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 97 Brazil COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 98 Mexico COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 99 Mexico COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 100 Mexico COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 101 Mexico COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 102 Mexico COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 103 MEA COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 104 MEA COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 105 MEA COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 106 MEA COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 107 MEA COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 108 South Africa COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 109 South Africa COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 110 South Africa COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 111 South Africa COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 112 South Africa COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 113 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 114 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 115 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 116 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 117 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Data triangulation techniques
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value-chain-based sizing & forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Market formulation & validation
  • FIG. 8 Market revenue modeling
  • FIG. 9 Market revenue modeling: Considerations
  • FIG. 10 Market revenue modeling: Considerations
  • FIG. 11 Market snapshot, 2020 (USD Million)
  • FIG. 12 COVID-19 diagnostics market segmentation
  • FIG. 13 Penetration & growth prospect mapping for technology, 2020
  • FIG. 14 Market driver relevance analysis (Current & future impact)
  • FIG. 15 Distribution of cases, as of 16th July 2020
  • FIG. 16 Distribution of cases, as of 4th June 2020
  • FIG. 17 Total number of cases in North America (1st March 2020-1st June 2020)
  • FIG. 18 Total number of cases in Europe (1st March 2020-1st June 2020)
  • FIG. 19 Total number of cases in Asia Pacific (excluding Oceania) (1st March 2020-1st June 2020)
  • FIG. 20 Total number of cases in Latin America countries (1st March 2020-1st June 2020)
  • FIG. 21 Total number of cases in South Africa (1st March 2020-1st June 2020)
  • FIG. 22 Market restrain relevance analysis (Current & future impact)
  • FIG. 23 Company Position Analysis
  • FIG. 24 Healthcare expenditure in China, 2013-2017
  • FIG. 25 Healthcare expenditure in Brazil, 2013-2017
  • FIG. 26 COVID-19 diagnostics market: Product & service outlook and key takeaways
  • FIG. 27 COVID-19 diagnostics market: Product & service movement analysis
  • FIG. 28 Global COVID-19 diagnostics reagents & kits market, 2020 - 2027 (USD Million)
  • FIG. 29 Global COVID-19 diagnostics instruments market, 2020 - 2027 (USD Million)
  • FIG. 30 Global COVID-19 diagnostic services market, 2020 - 2027 (USD Million)
  • FIG. 31 COVID-19 diagnostics market: Sample Type outlook and key takeaways
  • FIG. 32 COVID-19 diagnostics market: Sample type movement analysis
  • FIG. 33 Global COVID-19 diagnostics nasopharyngeal swabs market, 2020 - 2027 (USD Million)
  • FIG. 34 Global COVID-19 diagnostics oropharyngeal swabs market, 2020 - 2027 (USD Million)
  • FIG. 35 Global COVID-19 diagnostics blood market, 2020 - 2027 (USD Million)
  • FIG. 36 Global COVID-19 diagnostics other samples market, 2020 - 2027 (USD Million)
  • FIG. 37 COVID-19 diagnostics market: Test type outlook and key takeaways
  • FIG. 38 COVID-19 diagnostics market: Test type movement analysis
  • FIG. 39 Global COVID-19 molecular (PCR) testing market, 2020 - 2027 (USD Million)
  • FIG. 40 Global COVID-19 antigen-based testing market, 2020 - 2027 (USD Million)
  • FIG. 41 Global COVID-19 antibody (Serology) testing market, 2020 - 2027 (USD Million)
  • FIG. 42 Global COVID-19 diagnostics other tests market, 2020 - 2027 (USD Million)
  • FIG. 43 COVID-19 diagnostics market: Mode outlook and key takeaways
  • FIG. 44 COVID-19 diagnostics market: Mode movement analysis
  • FIG. 45 Global COVID-19 Point-of-Care (PoC) testing market, 2020 - 2027 (USD Million)
  • FIG. 46 Global COVID-19 non Point-of-Care (Non-PoC) testing market, 2020 - 2027 (USD Million)
  • FIG. 47 COVID-19 diagnostics market: End-use outlook and key takeaways
  • FIG. 48 COVID-19 diagnostics market: End-use movement analysis
  • FIG. 49 Global laboratories-based COVID-19 diagnostics market, 2020 - 2027 (USD Million)
  • FIG. 50 Global hospitals-based COVID-19 diagnostics market, 2020 - 2027 (USD Million)
  • FIG. 51 Global diagnostic centers and clinics-based COVID-19 diagnostics market, 2020 - 2027 (USD Million)
  • FIG. 52 Global research institutes-based COVID-19 diagnostics market, 2020 - 2027 (USD Million)
  • FIG. 53 COVID-19 diagnostics market: Regional outlook and key takeaways
  • FIG. 54 COVID-19 diagnostics market: Regional movement analysis
  • FIG. 55 North America
  • FIG. 56 North America COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 57 The U.S.
  • FIG. 58 The U.S. COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 59 Canada
  • FIG. 60 Canada COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 61 Europe
  • FIG. 62 Europe COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 63 Germany
  • FIG. 64 Germany COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 65 The U.K.
  • FIG. 66 The U.K.COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 67 France
  • FIG. 68 France COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 69 Italy
  • FIG. 70 Italy COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 71 Spain
  • FIG. 72 Spain COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 73 Russia
  • FIG. 74 Russia COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 75 Asia Pacific COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 76 China
  • FIG. 78 China COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 79 India
  • FIG. 80 India COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 81 Japan
  • FIG. 82 Japan COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 83 South Korea
  • FIG. 84 South Korea COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 85 Australia
  • FIG. 86 Australia COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 87 Latin America
  • FIG. 88 Latin America COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 89 Brazil
  • FIG. 90 Brazil COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 91 Mexico
  • FIG. 92 Mexico COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 93 Middle East & Africa
  • FIG. 94 MEA COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 95 South Africa
  • FIG. 96 South Africa COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 97 Saudi Arabia
  • FIG. 98 Saudi Arabia COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 99 Competition categorization
  • FIG. 100 Strategy framework
  • FIG. 101 Market participation categorization
目次
Product Code: GVR-4-68038-561-8

COVID-19 Diagnostics Market Growth & Trends

The global COVID-19 diagnostics market size is expected to reach USD 24.6 billion by 2027, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 3.1% during the forecast period. An increase in the need for mass testing and efficiency in diagnosing the infection are key contributors to market growth. As the number of COVID-19 cases is exponentially rising, the need to develop rapid and easy-to-use diagnostic and serology tests is also increasing. This has created opportunities for emerging players and new market entries, thereby driving market revenue.

Large-scale operational entities in Sweden, such as Tele2, H&M, and Spotify are engaged in mass testing for distinguishing the staff tested positive from uninfected. In addition, key players are constantly accelerating the production and supply of diagnostic tests to keep pace with the increasing need for disease containment. For instance, in May 2020, Roche introduced an antibody test which is recognized as 100% accurate by Public Health England.

Exploring the potential of novel molecular technologies in the scaling-up of coronavirus testing is expected to offer a significant momentum to the expansion of COVID-19 diagnostics space. For instance, CRISPR-a gene editing technology-has recently made its way into the coronavirus testing market. This gene-editing technology enables detection of SARS-CoV-2 genes, via a protein, namely, CRISPR-Cas12. Acknowledging the potential of this technology in diagnosing coronavirus patients, the Food and Drug Administration (FDA) recently approved the CRISPR test for coronavirus patients in the U.S. This diagnostic kit has been approved under the provisions of emergency use.

The expanding pool of startup companies actively operating in the market for COVID-19 diagnostics is also expected to intensify market participant competition. This trend has been prominently observed in the Asia Pacific region, contributing to the fast-paced growth expected to be witnessed by this region through 2021-2027. Some of the startup manufacturers of novel COVID-19 tests include Mylab, DNA Xperts Private Limited, Rokid, Bione, and SD Biosensor.

COVID-19 Diagnostics Market Report Highlights

Diagnostic service is estimated to capture the maximum revenue share owing to the introduction of policies and mandates to conduct testing at large scale globally

The nasopharyngeal swabs segment is estimated to dominate the market in 2020 with a revenue share of 48%, followed by an Oropharyngeal (OP) swab. Nasopharyngeal swabs are the gold standard for COVID-19 sample collection; both oropharyngeal and nasopharyngeal swabs are largely employed in PCR testing. This has propelled the expansion of point-of-care COVID-19 testing market space, which has contributed to the segment's fast-paced growth through 2021 to 2027

The increasing popularity of at-home testing and handheld instruments targeted toward combating the shortage of coronavirus test kits has been witnessed. This is expected to result in the lucrative growth of Point-of-Care (POC) testing during the forecast period

Laboratories are estimated to be the key revenue contributing end-users owing to the primary role of laboratories in sample testing for suspected individuals

Asia Pacific is projected to dominate the market for COVID-19 diagnostics in 2020 with a revenue share of around 37% and is expected to maintain this dominance during the forecast period. This is attributed to the robust funding for fast-track studies pertaining to clinical validation of rapid testing as well as the rapid launch of novel products. Robust government initiatives aimed at increasing the number of operational laboratories dedicated to coronavirus testing across Asian countries are set to propel the market growth

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates and Forecast Timeline
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.2 Volume Price Analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume Price Analysis
      • 1.6.2.2 revenue modeling
      • 1.6.2.3 Workflow mapping of covid-19 diagnostics
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources

Chapter 2 Executive Summary

  • 2.1 COVID-19 Diagnostics Market: Market Outlook
    • 2.1.1 Market Summary
  • 2.2 COVID-19 Diagnostics Market: Market Segmentation
  • 2.3 COVID-19 Diagnostics Market: Competitive Insights

Chapter 3 Industry Outlook

  • 3.1 Parent Market
  • 3.2 Penetration & Growth Prospect Mapping for Technology, 2020
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Increase in the incidence of coronavirus globally
      • 3.3.1.1.1 North America
      • 3.3.1.1.2 Europe
      • 3.3.1.1.3 Asia Pacific
      • 3.3.1.1.4 Latin America
      • 3.3.1.1.5 Middle East and Africa
      • 3.3.1.2 Increasing product approvals by regulatory agencies
      • 3.3.1.3 Government initiatives toward mass testing
      • 3.3.1.4 Paradigm shift toward POC testing
    • 3.3.2 Market restraint analysis
      • 3.3.2.1 Limited testing capacity
      • 3.3.2.2 Low demand due to supply ratio of COVID-19 reagents
    • 3.3.3 Market opportunity analysis
      • 3.3.3.1 Potential emerging markets
      • 3.3.3.2 Favorable riembursement scenario
      • 3.3.3.3 Increasing penetration of telehealth in diagnosis of Covid-19
    • 3.3.4 Market Challenge analysis
      • 3.3.4.1 Challenges pertaining to COVID-19 testing in healthcare settings
  • 3.4 COVID-19 Diagnostics Market - Porter's Analysis
    • 3.4.1 Porter's Analysis
      • 3.4.1.1 Competitive Rivalry - High
      • 3.4.1.2 Threat of New Entrants - MoDERATE
      • 3.4.1.3 Threat of Substitutes - Low
      • 3.4.1.4 Bargaining Power of Suppliers - Moderate
      • 3.4.1.5 Bargaining Power of Buyers - LoW
  • 3.5 COVID-19 Diagnostics Market - SWOT Analysis
    • 3.5.1 Political and Legal
      • 3.5.1.1 Strengths
      • 3.5.1.2 Weaknesses
      • 3.5.1.3 Opportunities
      • 3.5.1.4 Threats
    • 3.5.2 Economic
      • 3.5.2.1 Strengths
      • 3.5.2.2 Weakness
      • 3.5.2.3 Opportunity
      • 3.5.2.4 Threat
    • 3.5.3 Technological
      • 3.5.3.1 Strengths
      • 3.5.3.2 Weakness
      • 3.5.3.3 Opportunity
      • 3.5.3.4 Threat
  • 3.6 COVID-19 Diagnostics: Company Position Analysis
  • 3.7 COVID-19 Diagnostics: Healthcare Spending and Funding Scenario in Different Countries
    • 3.7.1 U.S.
    • 3.7.2 China
    • 3.7.3 Brazil
    • 3.7.4 Germany
    • 3.7.5 Others
  • 3.8 COVID-19 Diagnostics Market - Regulatory Framework
  • 3.9 Effect on Swabs Market
    • 3.9.1 Production shortage for viral transport media
    • 3.9.2 Companies Leading The Viral Transport Media Market
      • 3.9.2.1 Copan Diagnostics
      • 3.9.2.2 Puritan Medical Products
      • 3.9.2.3 Becton, Dickinson And Company (BD)
      • 3.9.2.4 Thermo Fisher Scientific
      • 3.9.2.5 Other Emerging Companies

Chapter 4 Product & Service Business Analysis

  • 4.1 Reagents & Kits
    • 4.1.1 Global COVID-19 Diagnostics reagents & kits market, 2020 - 2027 (USD Million)
  • 4.2 Instruments
    • 4.2.1 Global COVID-19 Diagnostics Instruments market, 2020 - 2027 (USD Million)
  • 4.3 Service
    • 4.3.1 Global COVID-19 Diagnostic services market, 2020 - 2027 (USD Million)

Chapter 5 SAMPLE TYPE Business Analysis

  • 5.1 COVID-19 Diagnostics Market: Sample Type Movement Analysis
  • 5.2 Nasopharyngeal Swabs
    • 5.2.1 Global COVID-19 Diagnostics nasopharyngeal swabs market, 2020 - 2027 (USD Million)
  • 5.3 Oropharyngeal Swabs
    • 5.3.1 Global COVID-19 Diagnostics oropharyngeal swabs market, 2020 - 2027 (USD Million)
  • 5.4 Blood
    • 5.4.1 Global COVID-19 Diagnostics blood market, 2020 - 2027 (USD Million)
  • 5.5 Others
    • 5.5.1 Global COVID-19 Diagnostics other SAmples market, 2020 - 2027 (USD Million)

Chapter 6 Test Type Business Analysis

  • 6.1 COVID-19 Diagnostics Market: Test Type Movement Analysis
  • 6.2 Molecular (PCR) Testing
    • 6.2.1 Global COVID-19 molecular (PCR) testing market, 2020 - 2027 (USD Million)
  • 6.3 Antigen-based Testing
    • 6.3.1 Global COVID-19 antigen-based testing market, 2020 - 2027 (USD Million)
  • 6.4 Antibody (Serology) Testing
    • 6.4.1 Global COVID-19 Diagnostics antibody (Serology) testing market, 2020 - 2027 (USD Million)
  • 6.5 Other Tests
    • 6.5.1 Global COVID-19 other tests market, 2020 - 2027 (USD Million)

Chapter 7 Mode Business Analysis

  • 7.1 COVID-19 Diagnostics Market: Mode Movement Analysis
  • 7.2 Point-of-Care (PoC) Testing
    • 7.2.1 Global COVID-19 Point-of-Care (PoC) testing market, 2020 - 2027 (USD Million)
  • 7.3 Non Point-of-Care (Non-PoC) Testing
    • 7.3.1 Global COVID-19 non Point-of-Care (Non-PoC) testing market, 2020 - 2027 (USD Million)

Chapter 8 End-use Business Analysis

  • 8.1 COVID-19 Diagnostics Market: End-use Movement Analysis
  • 8.2 Laboratories
    • 8.2.1 Global laboratories-based COVID-19 Diagnostics market, 2020 - 2027 (USD Million)
  • 8.3 Hospitals
    • 8.3.1 Global COVID-19 Diagnostics market, 2020 - 2027 (USD Million)
  • 8.4 Diagnostic Centers and Clinics
    • 8.4.1 Global diagnostic centers and clinics-based COVID-19 Diagnostics market, 2020 - 2027 (USD Million)
  • 8.5 Research Institutes
    • 8.5.1 Global research institutes-based COVID-19 Diagnostics market, 2020 - 2027 (USD Million)

Chapter 9 Regional Business Analysis

  • 9.1 COVID-19 Diagnostics Market: Regional Movement Analysis, 2020 & 2027
  • 9.2 North America
    • 9.2.1 North America COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
    • 9.2.2 The U.S.
      • 9.2.2.1 The U.S. COVID-19 diagnostics market estimates and forecast, by product, 2020 - 2027 (USD Million)
      • 9.2.2.2 The U.S. COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.2.2.3 The U.S. COVID-19 diagnostics market estimates and forecast, by technology, 2020 - 2027 (USD Million)
      • 9.2.2.4 The U.S. COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.2.3 Canada
      • 9.2.3.1 Canada COVID-19 diagnostics market estimates and forecast, by product, 2020 - 2027 (USD Million)
      • 9.2.3.2 Canada COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.2.3.3 Canada COVID-19 diagnostics market estimates and forecast, by technology, 2020 - 2027 (USD Million)
      • 9.2.3.4 Canada COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
  • 9.3 Europe
    • 9.3.1 Europe COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
    • 9.3.2 Germany
      • 9.3.2.1 Germany COVID-19 diagnostics market estimates and forecast, by product, 2020 - 2027 (USD Million)
      • 9.3.2.2 Germany COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.3.2.3 Germany COVID-19 diagnostics market estimates and forecast, by technology, 2020 - 2027 (USD Million)
      • 9.3.2.4 Germany COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.3.3 The U.K.
      • 9.3.3.1 The U.K. COVID-19 diagnostics market estimates and forecast, by product, 2020 - 2027 (USD Million)
      • 9.3.3.2 The U.K.COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.3.3.3 The U.K.COVID-19 diagnostics market estimates and forecast, by technology, 2020 - 2027 (USD Million)
      • 9.3.3.4 The U.K.COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.3.4 France
      • 9.3.4.1 France COVID-19 diagnostics market estimates and forecast, by product, 2020 - 2027 (USD Million)
      • 9.3.4.2 France COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.3.4.3 France COVID-19 diagnostics market estimates and forecast, by technology, 2020 - 2027 (USD Million)
      • 9.3.4.4 France COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.3.5 Italy
      • 9.3.5.1 Italy COVID-19 diagnostics market estimates and forecast, by product, 2020 - 2027 (USD Million)
      • 9.3.5.2 Italy COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.3.5.3 Italy COVID-19 diagnostics market estimates and forecast, by technology, 2020 - 2027 (USD Million)
      • 9.3.5.4 Italy COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.3.6 Spain
      • 9.3.6.1 Spain COVID-19 diagnostics market estimates and forecast, by product, 2020 - 2027 (USD Million)
      • 9.3.6.2 Spain COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.3.6.3 Spain COVID-19 diagnostics market estimates and forecast, by technology, 2020 - 2027 (USD Million)
      • 9.3.6.4 Spain COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.3.7 Russia
      • 9.3.7.1 Russia COVID-19 diagnostics market estimates and forecast, by product, 2020 - 2027 (USD Million)
      • 9.3.7.2 Russia COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.3.7.3 Russia COVID-19 diagnostics market estimates and forecast, by technology, 2020 - 2027 (USD Million)
      • 9.3.7.4 Russia COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
  • 9.4 Asia-Pacific
    • 9.4.1 Asia Pacific COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
    • 9.4.2 China
      • 9.4.2.1 China COVID-19 diagnostics market estimates and forecast, by product, 2020 - 2027 (USD Million)
      • 9.4.2.2 China COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.4.2.3 China COVID-19 diagnostics market estimates and forecast, by technology, 2020 - 2027 (USD Million)
      • 9.4.2.4 China COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.4.3 India
      • 9.4.3.1 India COVID-19 diagnostics market estimates and forecast, by product, 2020 - 2027 (USD Million)
      • 9.4.3.2 India COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.4.3.3 India COVID-19 diagnostics market estimates and forecast, by technology, 2020 - 2027 (USD Million)
      • 9.4.3.4 India COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.4.4 Japan
      • 9.4.4.1 Japan COVID-19 diagnostics market estimates and forecast, by product, 2020 - 2027 (USD Million)
      • 9.4.4.2 Japan COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.4.4.3 Japan COVID-19 diagnostics market estimates and forecast, by technology, 2020 - 2027 (USD Million)
      • 9.4.4.4 Japan COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.4.5 South Korea
      • 9.4.5.1 South Korea COVID-19 diagnostics market estimates and forecast, by product, 2020 - 2027 (USD Million)
      • 9.4.5.2 South Korea COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.4.5.3 South Korea COVID-19 diagnostics market estimates and forecast, by technology, 2020 - 2027 (USD Million)
      • 9.4.5.4 South Korea COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.4.6 Australia
      • 9.4.6.1 Australia COVID-19 diagnostics market estimates and forecast, by product, 2020 - 2027 (USD Million)
      • 9.4.6.2 Australia COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.4.6.3 Australia COVID-19 diagnostics market estimates and forecast, by technology, 2020 - 2027 (USD Million)
      • 9.4.6.4 Australia COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Latin America COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
    • 9.5.2 Brazil
      • 9.5.2.1 Brazil COVID-19 diagnostics market estimates and forecast, by product, 2020 - 2027 (USD Million)
      • 9.5.2.2 Brazil COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.5.2.3 Brazil COVID-19 diagnostics market estimates and forecast, by technology, 2020 - 2027 (USD Million)
      • 9.5.2.4 Brazil COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.5.3 Mexico
      • 9.5.3.1 Mexico COVID-19 diagnostics market estimates and forecast, by product, 2020 - 2027 (USD Million)
      • 9.5.3.2 Mexico COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.5.3.3 Mexico COVID-19 diagnostics market estimates and forecast, by technology, 2020 - 2027 (USD Million)
      • 9.5.3.4 Mexico COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
  • 9.6 The Middle East and Africa (MEA)
    • 9.6.1 MEA COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
    • 9.6.2 South Africa
      • 9.6.2.1 South Africa COVID-19 diagnostics market estimates and forecast, by product, 2020 - 2027 (USD Million)
      • 9.6.2.2 South Africa COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.6.2.3 South Africa COVID-19 diagnostics market estimates and forecast, by technology, 2020 - 2027 (USD Million)
      • 9.6.2.4 South Africa COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.6.3 Saudi Arabia
      • 9.6.3.1 Saudi Arabia COVID-19 diagnostics market estimates and forecast, by product, 2020 - 2027 (USD Million)
      • 9.6.3.2 Saudi Arabia COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.6.3.3 Saudi Arabia COVID-19 diagnostics market estimates and forecast, by technology, 2020 - 2027 (USD Million)
      • 9.6.3.4 Saudi Arabia COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)

Chapter 10 Competitive Landscape

  • 10.1 Company/Competition Categorization (Key Innovators, Market leaders, Emerging Players)
  • 10.2 Strategy Framework
  • 10.3 Market Participation Categorization
  • 10.4 Recent Developments & Impact Analysis, by Key Market Participants
  • 10.5 Company Profiles
    • 10.5.1 F. Hoffmann-La Roche AG
      • 10.5.1.1 Company overview
      • 10.5.1.2 Financial performance
      • 10.5.1.3 Product benchmarking
      • 10.5.1.4 Strategic initiatives
    • 10.5.2 Thermo Fisher Scientific, Inc.
      • 10.5.2.1 Company overview
      • 10.5.2.2 Financial performance
      • 10.5.2.3 Product benchmarking
      • 10.5.2.4 Strategic initiatives
    • 10.5.3 PerkinElmer, Inc.
      • 10.5.3.1 Company overview
      • 10.5.3.2 Financial performance
      • 10.5.3.3 Product benchmarking
      • 10.5.3.4 Strategic initiatives
    • 10.5.4 1drop, Inc.
      • 10.5.4.1 Company overview
      • 10.5.4.2 Product benchmarking
      • 10.5.4.3 Strategic initiatives
    • 10.5.5 Veredus Laboratories
      • 10.5.5.1 Company overview
      • 10.5.5.2 Financial performance (Sekisui Chemical Co., Ltd.)
      • 10.5.5.3 Product benchmarking
      • 10.5.5.4 Strategic initiatives
    • 10.5.6 ADT Biotech Sdn Bhd
      • 10.5.6.1 Company overview
      • 10.5.6.2 Product benchmarking
      • 10.5.6.3 Strategic initiatives
    • 10.5.7 altona Diagnostics GmbH
      • 10.5.7.1 Company overview
      • 10.5.7.2 Product benchmarking
      • 10.5.7.3 Strategic initiatives
    • 10.5.8 bioMerieux SA
      • 10.5.8.1 Company overview
      • 10.5.8.2 Financial performance
      • 10.5.8.3 Product benchmarking
      • 10.5.8.4 Strategic initiatives
    • 10.5.9 Neuberg Diagnostics
      • 10.5.9.1 Company overview
      • 10.5.9.2 Product benchmarking
      • 10.5.9.3 Strategic initiatives
    • 10.5.10 Abbott Laboratories
      • 10.5.10.1 Company overview
      • 10.5.10.2 Financial performance
      • 10.5.10.3 Product benchmarking
      • 10.5.10.4 Strategic Initiatives
    • 10.5.11 Luminex Corporation
      • 10.5.11.1 Company overview
      • 10.5.11.2 Financial performance
      • 10.5.11.3 Product benchmarking
      • 10.5.11.4 Strategic Initiatives
    • 10.5.12 Laboratory Corporation of America Holdings
      • 10.5.12.1 Company overview
      • 10.5.12.2 Financial performance
      • 10.5.12.3 Product benchmarking
      • 10.5.12.4 Strategic Initiatives
    • 10.5.13 Hologic Inc
      • 10.5.13.1 Company overview
      • 10.5.13.2 Financial performance
      • 10.5.13.3 Product benchmarking
      • 10.5.13.1 Strategic Initiatives
    • 10.5.14 Quest Diagnostics, Inc.
      • 10.5.14.1 Company overview
      • 10.5.14.2 Financial performance
      • 10.5.14.3 Product benchmarking
      • 10.5.14.4 Strategic Initiatives
    • 10.5.15 Quidel Corporation
      • 10.5.15.1 Company overview
      • 10.5.15.2 Financial performance
      • 10.5.15.3 Product benchmarking
      • 10.5.15.4 Strategic Initiatives
    • 10.5.16 ALDATU BIOSCIENCES
      • 10.5.16.1 Company overview
      • 10.5.16.2 Product benchmarking
      • 10.5.16.3 Strategic Initiatives
    • 10.5.17 Mylab Discovery Solutions Pvt Ltd.
      • 10.5.17.1 Company overview
      • 10.5.17.2 Product benchmarking
      • 10.5.17.3 Strategic Initiatives
    • 10.5.18 Danaher Corporation
      • 10.5.18.1 Company overview
      • 10.5.18.2 Financial performance
      • 10.5.18.3 Cepheid
      • 10.5.18.3.1 Company overview
      • 10.5.18.3.2 Product benchmarking (Cepheid)
      • 10.5.18.3.3 Strategic Initiatives
      • 10.5.18.4 Beckman Coulter, Inc.
      • 10.5.18.4.1 Company overview
      • 10.5.18.4.2 Product benchmarking (Beckman Coulter)
      • 10.5.18.4.3 Strategic Initiatives
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.